Chatterjee et al. found that Caspase-1 inhibitor VX765 inhibited caspase 1-mediated IL-1β production and Gasdermin D processing, enhanced LC3 expression in lesions, and was effective in alleviating vascular inflammation and atherosclerosis [74]. This evidence concerns the gene MAP1LC3A and atherosclerosis.